Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 13, 2026, titled "Intimation of Earnings call".
Dr. Reddy's Laboratories Ltd. Press Release Jul 13 2026
Earlier from Dr. Reddy's Laboratories
- Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F
- Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
- Dr Reddy Laboratories: Annual Report for Fiscal Year Ending March 31, 2026 (Form 20-F)
- Press Release May 28 2026